Internal Biomarker Discovery Research
Various Diseases
ResearchActive
Key Facts
About MZ Biolabs
MZ Biolabs is a private, early-revenue stage company operating as a specialty testing and discovery services provider. Its core business leverages state-of-the-art mass spectrometry (including HPLC, ESI/APCI sources, and QTOF instruments) to deliver precise analytical data for clients in pharmaceutical, academic, and clinical sectors. The company differentiates itself through deep expertise in custom method development, a DEA license for handling controlled substances, and active internal research into disease biomarkers. With a small, experienced team, MZ Biolabs positions itself as a nimble and responsive partner for complex analytical challenges.
View full company profileTherapeutic Areas
Other Various Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| New Target Biology | Biovista | Service |
| Target Discovery & Validation Platform | Paradigm4 | N/A |
| Biomarker Research Services | PolyQuant | Discovery/Validation |